Creative Medical Technology (NASDAQ:CELZ) Raised to “Sell” at Wall Street Zen
Creative Medical Technology (NASDAQ:CELZ – Get Free Report) was upgraded by investment analysts at Wall Street Zen to a “sell” rating in a research report issued to clients and investors on Saturday. Several other research firms have also recently weighed in on CELZ. Weiss Ratings…
Creative Medical Technology (NASDAQ:CELZ – Get Free Report) was upgraded by investment analysts at Wall Street Zen to a “sell” rating in a research report issued to clients and investors on Saturday. Several other research firms have also recently weighed in on CELZ. Weiss Ratings upgraded Creative Medical Technology from a “sell (e+)” rating to […]